Brain Microstructure and Impulsivity Differ between Current and Past Methamphetamine Users.

J Neuroimmune Pharmacol

Neuroscience and MR Research Program, John A. Burn School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.

Published: September 2016

Methamphetamine (Meth) use disorder continues to be highly prevalent worldwide. Meth users have higher impulsivity and brain abnormalities that may be different between current and past Meth users. The current study assessed impulsivity and depressive symptoms in 94 participants (27 current Meth users, 32 past Meth users and 35 non-drug user controls). Additionally, brain microstructure was assessed using diffusion tensor imaging (DTI); fractional anisotropy (FA) and mean diffusivity (MD) were assessed in the striatum, and FA, MD, radial and axial diffusivity were quantified in five white matter structures using DtiStudio.Across the three subject groups, current users had the highest self-reported impulsivity scores, while both Meth user groups had larger striatal structures than the controls. Past Meth users had the highest FA and lowest MD in the striatum, which is likely due to greater magnetic susceptibility from higher iron content and greater dendritic spine density. In white matter tracts, current Meth users had higher AD than past users, indicating greater water diffusion along the axons, and suggesting inflammation with axonal swelling. In contrast, past users had the lowest AD, indicating more restricted diffusion, which might have resulted from reactive gliosis. Although current Meth users had greater impulsivity than past users, the brain microstructural abnormalities showed differences that may reflect different stages of neuroinflammation or iron-induced neurodegeneration. Combining current and past Meth users may lead to greater variability in studies of Meth users. Longitudinal studies are needed to further evaluate the relationship between recency of Meth use and brain microstructure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467202PMC
http://dx.doi.org/10.1007/s11481-016-9675-8DOI Listing

Publication Analysis

Top Keywords

meth users
36
current meth
20
users
14
brain microstructure
12
meth
12
current
8
users higher
8
white matter
8
users highest
8
brain
5

Similar Publications

Methamphetamine inhibits huntingtin-associated protein 1-mediated tyrosine receptor kinase B endocytosis resulting the neuroprotective dysfunction of brain-derived neurotrophic factor.

Toxicology

January 2025

School of Forensic Medicine, National Health Commission (NHC) Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, Yunnan 650500, China. Electronic address:

Methamphetamine (METH), a synthetic stimulant, has seen an escalating abuse situation globally over the past decade. Although the molecular mechanism underlying METH-induced neurotoxicity has been explored, the dysfunction of brain-derived neurotrophic factor (BDNF) neuroprotection in the context of METH neurotoxicity remains insufficiently understood. Our previous studies have found that METH induced neurotoxicity and BDNF expression in rat primary neurons, necessitating further research into this paradox.

View Article and Find Full Text PDF

Introduction: Glutathione S-transferase (GST) has the ability to detoxify the cellular environment of xenobiotic compounds and by-products of oxidative stress. The expression levels of GST genes and their polymorphisms are associated with various human diseases. Methamphetamine and opiate addiction also account for a significant proportion of SUDs in Iran.

View Article and Find Full Text PDF
Article Synopsis
  • A study explored the link between kratom use and aggression among male methamphetamine (METH) users, involving 403 participants and various clinical measures.
  • No significant differences in aggression levels were found between METH users and those with a history of kratom use, although two distinct clusters of users emerged based on their kratom consumption patterns.
  • In Cluster 1, higher kratom use correlated with increased aggression, while in Cluster 2, lower frequency of kratom use acted as a protective factor against aggression, suggesting that moderate kratom use may reduce aggression in some METH users.
View Article and Find Full Text PDF
Article Synopsis
  • The development of translational biomarkers is essential for diagnosing and monitoring diseases, especially in complex conditions like HIV-associated neurocognitive impairment (NCI), where diverse factors can complicate analysis.
  • Substance use, particularly methamphetamine (METH), exacerbates cognitive deficits in people living with HIV (PWH), and current biomarkers fail to highlight the differences in their disease trajectory compared to non-users.
  • Researchers hypothesized that certain signatures in blood cells related to dopamine levels can differentiate between HIV+ METH users and other groups, revealing neuroimmune mechanisms linked to depression and aiding in the identification of affected individuals through specific gene variations.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the rising use of methamphetamine over the past decade and aims to systematically review the reasons why people use this drug, as no comprehensive reviews have been conducted on this topic before.
  • After analyzing 25,004 articles from various databases, 21 were selected that met specific criteria, uncovering motivations such as performance enhancement, socializing, coping with problems, and managing withdrawal symptoms.
  • The findings underscore the importance of providing accurate information about methamphetamine and developing interventions to help users cope with withdrawal and prevent addiction.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!